Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (231-240 of 250) with videos related to

Pageof 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisKevin Hollevoet, Johannes B Reitsma, Jenette Creaney, et al.
The Lancet. Oncology|June 24, 2017
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trialCorinne Faivre-Finn, Michael Snee, Linda Ashcroft, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomesT Le Chevalier, G Scagliotti, R Natale, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2020
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populationsEnriqueta Felip, Andrea Ardizzoni, Tudor Ciuleanu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 2, 2010
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trialsJohn T Maringwa, Chantal Quinten, Madeleine King, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?Denis Horgan, Anne-Marie Baird, Mark Middleton, et al.
JAMA|November 25, 2010
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trialJouke T Annema, Jan P van Meerbeeck, Robert C Rintoul, et al.
Cancers|August 29, 2018
A Multicenter Study to Assess <i>EGFR</i> Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical SettingLaure Sorber, Karen Zwaenepoel, Koen De Winne, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2021
Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?José S A Belderbos, Dirk K M De Ruysscher, Katrien De Jaeger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2021
Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675)José S A Belderbos, Dirk K M De Ruysscher, Katrien De Jaeger, et al.
Pageof 25

Showing results (231-240 of 250) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisKevin Hollevoet, Johannes B Reitsma, Jenette Creaney, et al.
The Lancet. Oncology|June 24, 2017
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trialCorinne Faivre-Finn, Michael Snee, Linda Ashcroft, et al.
Lung Cancer (Amsterdam, Netherlands)|December 18, 2004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomesT Le Chevalier, G Scagliotti, R Natale, et al.
European Journal of Cancer (Oxford, England : 1990)|February 7, 2020
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populationsEnriqueta Felip, Andrea Ardizzoni, Tudor Ciuleanu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 2, 2010
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trialsJohn T Maringwa, Chantal Quinten, Madeleine King, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?Denis Horgan, Anne-Marie Baird, Mark Middleton, et al.
JAMA|November 25, 2010
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trialJouke T Annema, Jan P van Meerbeeck, Robert C Rintoul, et al.
Cancers|August 29, 2018
A Multicenter Study to Assess <i>EGFR</i> Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical SettingLaure Sorber, Karen Zwaenepoel, Koen De Winne, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 26, 2021
Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?José S A Belderbos, Dirk K M De Ruysscher, Katrien De Jaeger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 5, 2021
Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675)José S A Belderbos, Dirk K M De Ruysscher, Katrien De Jaeger, et al.
Pageof 25